Clinical Trial Update: Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and immunogenicity of different meningitis vaccine formulations in adolescents and young adults with completed results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Meningococcal Disease

Drugs mentioned

• Novartis meningococcal vaccine formulations (unspecified)

Snippet

Sponsor: Novartis Vaccines | Conditions: Invasive Meningococcal Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-09-26